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Webfigure 1: All−cause mortality vs. BMI in the range 15−50 kg/m2, by age at risk
(excluding the first 5 years of follow-up)
UDV3:[VEP.PSC.FIGURES.BMI.OCT08]web−allcauses−age.CTRL: 24−OCT−2008 09:12:16.11                                                     
Baseline BMI (kg/m2)











































































































































































































































































































































































































Webfigure 2: IHD mortality vs. BMI for never-smokers in the range 15−50 kg/m2
(excluding the first 5 years of follow-up)
UDV3:[VEP.PSC.FIGURES.BMI.OCT08]web−ihd.CTRL: 29−OCT−2008 14:49:36.29                                                               
Baseline BMI (kg/m2)





































































Webfigure 3: Stroke mortality vs. BMI in the range 15−50 kg/m2
excluding (a) the first 5 years of follow−up, (b) the first 10 years of follow−up,
or (c) the first 5 years of follow−up and those who had ever smoked
UDV3:[VEP.PSC.FIGURES.BMI.OCT08]web−stroke−fu.CTRL: 20−OCT−2008 15:55:19.70                                                         
Baseline BMI (kg/m2)






















































































































(a) Excluding first 5 years of follow-up
Baseline BMI (kg/m2)






















































































































(b) Excluding first 10 years of follow-up
Baseline BMI (kg/m2)






















































































































(c) Excluding first 5 years and ever smokers
Webfigure 4: Stroke subtype mortality vs. BMI in the range 15−50 kg/m2
(excluding the first 5 years of follow−up)
UDV3:[VEP.PSC.FIGURES.BMI.OCT08]web−stroke−type.CTRL: 23−OCT−2008 10:30:49.81                                                       
Baseline BMI (kg/m2)










































































































































































































































































































































































Webfigure 5: IHD and stroke mortality vs. BMI, by study:
hazard ratio per 5 kg/m2 higher BMI in the range 25−50 kg/m2
(excluding the first 5 years of follow-up)
UDV3:[VEP.PSC.FIGURES.BMI.OCT08]hetro−all.CTRL: 24−NOV−2008 10:59:42.41                                                             
No. of
deathsa) IHD mortality
















Studies with <200 deaths 2438
ALL STUDIES 10 783
Test for heterogeneity: χ162=22·5 (p=0·13)
b) Stroke mortality








Studies with <100 deaths 1475
ALL STUDIES 3164
Test for heterogeneity: χ82=6·1 (p=0·64)
0·8 1·0 1·4 2·0 2·8
Hazard ratio (& 99% CI) for
5 kg/m2 higher baseline BMI
Webfigure 6: COPD mortality vs. baseline BMI in the range 15−50 kg/m2
(by follow−up period)
UDV3:[VEP.PSC.FIGURES.BMI.OCT08]web−copd−notop.CTRL: 24−NOV−2008 09:26:52.25                                                        
Baseline BMI (kg/m2)



























































(BMI 35−50 kg/m2: 4 deaths, not plotted)
(a) 0−4 years (342 deaths)
Baseline BMI (kg/m2)



























































(BMI 35−50 kg/m2: 6 deaths, not plotted)
(b) 5−9 years (546 deaths)
Baseline BMI (kg/m2)



























































(BMI 35−50 kg/m2: 7 deaths, not plotted)
(c) 10−14 years (596 deaths)
Baseline BMI (kg/m2)



























































(BMI 35−50 kg/m2: 6 deaths, not plotted)
(d) 15+ years (812 deaths)
Webfigure 7: All−cause mortality vs. BMI by baseline smoking status
(excluding the first 5 years of follow-up)
                                             
Baseline BMI (kg/m2)





















































































(a) Male (35−69 years)
Baseline BMI (kg/m2)





















































































(b) Female (35−69 years)
Baseline BMI (kg/m2)





















































































(c) Male (70−79 years)
Baseline BMI (kg/m2)





















































































(d) Female (70−79 years)
Webfigure 8: Vascular mortality vs. BMI by baseline smoking status
(excluding the first 5 years of follow-up)
                                            
Baseline BMI (kg/m2)
















































































(BMI 35−50 kg/m2: 147 deaths, not plotted)
(a) Male (35−69 years)
Baseline BMI (kg/m2)
















































































(BMI 35−50 kg/m2: 178 deaths, not plotted)
(b) Female (35−69 years)
Baseline BMI (kg/m2)
















































































(BMI 35−50 kg/m2: 46 deaths, not plotted)
(c) Male (70−79 years)
Baseline BMI (kg/m2)
















































































(BMI 35−50 kg/m2: 174 deaths, not plotted)
(d) Female (70−79 years)
Webtable 1: Characteristics of 56 collaborating studies with data on BMI*
Study, by region and median 
year of assessment                          










Europe and Israel (32 studies)
Seven Countries, Croatia 1958 1 305 0 23.0 (3.2)  645 68 (7) 1976
Seven Countries, Finland 1959 1 487 0 23.7 (3.2)  712 67 (7) 1976
Seven Countries, Greece 1960 1 155 0 23.1 (3.3)  371 69 (7) 1979
Seven Countries, Italy 1960 2 310 0 25.6 (3.7)  897 67 (7) 1977
Seven Countries, Netherlands 1960  829 0 24.0 (2.7)  360 68 (7) 1978
Israeli IHD 1963 9 849 0 25.6 (3.3) 3 085 68 (8) 1979
Seven Countries, Serbia 1963  964 0 23.7 (3.5)  476 68 (7) 1980
Whitehall, UK 1968 18 863 0 24.7 (3.0) 2 737 66 (7) 1979
Gothenburg Women, Sweden 1969 1 406 100 24.0 (3.7)  259 68 (8) 1988
Finnish Mobile Clinic 1970 46 815 47 24.5 (4.0) 7 903 68 (12)     †
Paris PS, France 1970 7 517 0 25.9 (3.3) 1 938 64 (6) 1986
Midspan, UK 1971 6 602 14 25.0 (3.1) 1 714 66 (8) 1987
UK HDPP 1972 13 398 0 25.3 (3.2) 3 410 68 (7) 1990
Oslo, Norway 1973 15 692 0 24.7 (2.9) 1 738 58 (5) 1986
Northwick Park HS, UK 1975 3 334 31 24.9 (3.3)  446 68 (9) 1988
Renfrew/Paisley, UK 1975 11 205 55 25.6 (3.8) 2 320 68 (6) 1986
Norwegian Counties 1976 46 805 50 24.9 (3.6) 2 791 55 (5)     †
CB Project, Netherlands 1977 48 725 52 24.6 (3.4) 1 083 52 (6) 1988
Copenhagen, Denmark 1977 13 749 55 25.2 (4.2) 3 640 71 (9) 1989
Finrisk, Finland 1977 37 573 52 26.1 (4.2) 3 973 63 (9) 1988
BUPA, UK 1978 21 187 0 25.1 (2.8) 1 862 65 (8) 1990
BRHS, UK 1979 7 401 0 25.5 (3.2) 1 029 63 (6) 1990
Tromso, Norway 1979 14 361 48 23.7 (3.2)  275 53 (7) 1988
OG-Rome, Italy 1980 3 168 0 26.5 (3.2)  225 65 (5) 1987
Speedwell, UK 1980 1 870 0 25.5 (3.2)  256 66 (5) 1991
Caerphilly, UK 1981 1 891 0 26.0 (3.5)  240 63 (5) 1991
IPC-Paris, France 1982 180 039 44 23.8 (3.4) 3 860 60 (12) 1991
BIRNH, Belgium 1983 10 559 48 25.9 (4.1)  575 70 (9) 1990
Glostrup, Denmark 1983 9 140 50 24.8 (4.0)  529 68 (12) 1990
PROCAM, Germany 1983 13 580 24 26.0 (3.4)  176 59 (7) 1990
Scottish HHS 1986 12 514 51 25.7 (4.1)  523 60 (6) 1993
FLEMENGHO (Leuven), Belgium 1987 1 212 51 25.9 (4.1)  50 73 (10) 1993
Subtotals & averages‡ 1978 (1972§) 566 505 37 24.7 (3.6) 50 098 65 (10) 1987
United States and Australia (17 studies)
Framingham, US 1950 5 072 56 25.5 (4.1) 2 920 72 (10) 1977
Tecumseh, US 1960 4 288 52 25.8 (4.6) 1 241 70 (11) 1977
Charleston, US 1961 2 066 56 25.4 (4.8) 1 117 71 (10) 1980
Honolulu, US 1967 7 582 0 23.8 (3.1) 2 866 74 (8) 1985
Puerto Rico HHP, US (admin) 1967 9 167 0 25.1 (4.1) 1 156 66 (7) 1976
Busselton, Australia 1969 6 542 52 24.5 (3.7) 1 428 74 (11) 1986
NHEFS, US 1973 12 979 60 25.5 (4.9) 3 131 74 (11) 1985
Rancho Bernardo, US 1973 5 333 56 24.4 (3.5) 1 409 78 (9) 1986
Lipid Research Clinic, US 1974 8 165 46 26.0 (4.2)  995 69 (12) 1985
Physicians' HS, US 1982 22 058 0 24.9 (3.0) 1 435 71 (10) 1991
Perth, Australia 1983 9 272 49 25.2 (3.9)  552 69 (11) 1993
Minnesota HHP, US 1984 15 164 55 26.1 (4.7)  213 69 (11) 1989
Minnesota HS, US 1985 8 494 54 26.4 (4.8)  116 67 (11) 1989
Health Professionals, US 1986 46 717 0 25.5 (3.1)  648 67 (9) 1992
ARIC, US 1988 14 774 57 27.5 (5.2)  474 64 (5) 1995
Nurses' HS, US** 1988 78 069 100 25.6 (4.8)  417 64 (6) 1993
CHS, US 1989 4 493 60 26.4 (4.6)  25 77 (6) 1994
Subtotals & averages‡ 1986 (1968§) 260 235 50 25.6 (4.3) 20 143 72 (10) 1985
Japan† (8 studies)
Seven Countries, Japan 1958  954 0 22.0 (2.4)  399 68 (7) 1975
Japan Railway: EJR 1976 50 039 0 22.7 (2.7)  857 55 (4) 1982
Noichi 1976 2 180 63 22.9 (3.2)  290 72 (9) 1988
Ikawa 1977 2 098 56 23.6 (3.2)  266 71 (9) 1988
Shibata 1977 2 246 58 22.4 (3.0)  388 75 (10) 1987
Kyowa 1983 4 099 57 23.5 (3.3)  184 68 (8) 1991
Saitama 1987 3 406 63 22.4 (2.9)  109 72 (10) 1993
Ohasama 1990 2 814 62 23.6 (3.1)  15 74 (12) 1995
Subtotals & averages‡ 1977 (1975§) 67 836 15 22.8 (2.9) 2 508 66 (11) 1984
TOTALS & AVERAGES‡ 1979 (1972§) 894 576 39 24.8 (3.8) 72 749 67 (11)†† 1986
* References to all 61 PSC studies are in Lancet 2002;360:1903-13 (Appendix A). Excluded from these BMI analyses are 3 studies without BMI data (MRFIT,   
Evans County and Shanghai), 1 study with BMI data in broad categories only (Värmland), and 1 study without IHD mortality data (Seven Cities China).
† Data unavailable. Median year of death during all follow-up: 1985 (Finnish Mobile Clinic), 1987 (Norwegian Counties). 
‡ Where available; weighted for number of individuals  
§ Median year of assessment of those who died after 5 or more years of follow-up
** Nurses who had a cholesterol measurement in about 1988




Mean (SD)     
age at death
Excluding 1st 5 years of follow-up
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Webtable 2: Mortality endpoints and their ICD-9* codes
Endpoint name ICD-9 codes Notes
ALL VASCULAR DISEASE 390-459, 798 Includes sudden death and hypertensive renal disease
Ischaemic heart disease (IHD) 410-414
Stroke 430-438
Ischaemic stroke 433-434
Haemorrhagic stroke 431-432 Mainly intracerebral haemorrhage (and excludes subarachnoid haem.)
Subarachnoid haemorrhage 430
Unclassified stroke 435-438 Includes (miscertified) transient cerebral ischaemia
Other vascular disease Remainder of vascular Some such deaths could not be further subdivided in the PSC
Aortic aneurysm 441
Pulmonary embolism 415 Includes acute cor pulmonale, but not deep vein thrombosis
Heart failure 428
Hypertensive disease 401-405 Includes essential hypertension and hypertensive renal disease
Atherosclerosis & other arterial disease 440, 442-448 Includes peripheral arterial disease, & diseases of arterioles/capillaries
Inflammatory heart disease 420-424 Includes pericarditis, myocarditis, endocarditis
Rheumatic heart disease 390-398
Sudden death 798
Other heart disease (not IHD) 416-417, 425-427, 429 Includes pulmonary heart disease, cardiomyopathy, dysrhythmia
Other circulatory disease 451-459 Includes venous disease
Diabetes (any type) 250 In some countries, rarely recorded as the underlying cause
Kidney disease (non-neoplastic) 580-589 Excludes hypertensive renal disease
Liver disease (non-neoplastic) 070, 570-573
Cirrhosis 571
ALL NEOPLASTIC DISEASE 140-208 Excludes benign neoplasms
Liver cancer 155 Includes intrahepatic bile ducts; excludes known secondary cancers
Kidney cancer 189
Female breast cancer, age < 60 174 Deaths at ages 35-59 only
Female breast cancer, age ≥ 60 174 Deaths at ages 60-89 only
Ovarian cancer 183
Endometrial cancer 182 Includes all cancers of body of the uterus
Prostate cancer 185
Pancreatic cancer 157
Gallbladder cancer 156 Includes extrahepatic bile ducts
Stomach cancer 151
Colorectal cancer 153-154
Upper aerodigestive cancer 140-150,161 Mouth, pharynx, larynx, oesophagus
Oesophageal cancer 150





Unspecified cancer 195-199 Unspecified to the PSC
Other specified cancer (in webtable 7†) Remainder of neoplastic Excludes benign neoplasms
ALL RESPIRATORY DISEASE 010-012, 460-519 Includes influenza
Chronic obstructive pulmonary disease 490-496 Includes asthma
Pneumonia 480-486
Respiratory tuberculosis 010-012
Other respiratory disease Remainder of 
respiratory
Includes influenza
Other specified disease Remainder of 001-779
External cause (E)800-999 Mostly injury
Unknown cause (in webtable 7†) 780-797, 799 Unknown to the PSC
ALL CAUSES 001-999
* Not all studies provided ICD-9 codes. When other ICD versions or the study’s own codes were provided, these were grouped to
approximate as closely as possible the endpoints shown here. 
† In table 2 and webtable 9, other specified cancer was defined as all specified cancers other than lung and upper aerodigestive cancer. 
In table 2, unknown cause was defined as ICD-9 codes 195-199, 780-797 and 799.
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Webtable 3: Change in BMI from baseline to a repeat measurement, by age and sex 
No. No. Change (SE) No. Change (SE) r (SE)‡ No. Change (SE)
Male 15-19 3 510 17.2 1956 1.75 19.95  82 1.15 (0.17)  70 1.86 (0.16) 0.88 (0.028)  96 3.72 (0.24)
20-29 27 724 26.0 1953 1.76 23.29 1 317 0.49 (0.04) 2 222 1.01 (0.04) 0.87 (0.005)  733 2.41 (0.10)
30-39 88 766 35.3 1944 1.75 24.60 3 517 0.30 (0.02) 5 813 0.78 (0.02) 0.89 (0.003) 1 058 1.42 (0.07)
40-49 205 599 44.4 1932 1.74 25.28 9 290 0.11 (0.01) 34 782 0.18 (0.01) 0.91 (0.001) 1 451 1.06 (0.05)
50-59 138 176 53.7 1923 1.73 25.57 14 303 -0.01 (0.01) 16 977 0.13 (0.01) 0.92 (0.001)  722 0.46 (0.08)
60-69 41 389 63.3 1916 1.71 25.33 5 686 -0.08 (0.02) 4 804 0.02 (0.03) 0.90 (0.003)  575 -0.31 (0.10)
70-79 7 679 72.6 1909 1.70 24.91 1 542 0.10 (0.03) 1 076 -0.44 (0.05) 0.88 (0.007)  105 -1.31 (0.21)
80-89  506 82.0 1899 1.68 24.38  271 0.02 (0.06)  125 -0.73 (0.16) 0.86 (0.023)  0 -
Female 15-19 3 647 17.2 1957 1.63 20.04  81 0.93 (0.28)  74 0.64 (0.32) 0.68 (0.063)  95 3.53 (0.40)
20-29 29 779 25.7 1953 1.63 21.82 1 362 0.27 (0.05) 2 333 0.77 (0.05) 0.84 (0.006) 1 123 2.17 (0.10)
30-39 73 310 35.1 1944 1.62 23.09 2 403 0.33 (0.04) 4 398 0.96 (0.03) 0.87 (0.004) 1 536 1.90 (0.08)
40-49 103 458 44.5 1937 1.61 24.56 5 920 0.45 (0.02) 8 215 0.94 (0.02) 0.91 (0.002) 1 373 1.38 (0.08)
50-59 82 340 54.2 1929 1.60 25.34 8 804 0.21 (0.02) 8 317 0.65 (0.02) 0.91 (0.002)  790 0.56 (0.10)
60-69 41 391 63.3 1921 1.59 25.40 4 884 0.08 (0.02) 4 581 0.16 (0.03) 0.90 (0.003)  772 -0.79 (0.11)
70-79 5 046 72.7 1906 1.56 25.33 1 855 -0.01 (0.03) 1 412 -0.55 (0.06) 0.87 (0.006)  149 -2.08 (0.28)
80-89  504 82.1 1897 1.54 24.40  242 0.02 (0.09)  131 -1.19 (0.21) 0.82 (0.029)  0 -
Both sexes, all ages 852 824 46.0 1932 - 24.76 61 559 0.14 (0.01) 95 330 0.36 (0.01) 0.90 (0.001) 10 578 1.16 (0.03)
* Excluding 41 752 with less than 5 years of follow-up, and standardising mean height and BMI for study
† For the 755 890 participants with data on year of birth
‡ Self-correlation (within these age groups) between baseline BMI and BMI measured between 5-9 years of follow-up. The overall value of 0.90 is adjusted for the age/sex categories in
this table. This value of 0.90 might suggest that the associations of risk with baseline BMI underestimate the associations with usual BMI by about 10%, but this regression dilution was 
counterbalanced by a slight tendency of BMI values to disperse (webtable 4), so the underestimation was probably even less than 10%, and, therefore, of little importance (particularly 
during the first decade of follow-up).
No. of people at baseline, and their                       
mean age, height and BMI:*
No. of people resurveyed, and their                                                         














0-4 (mean 2.6) years 5-9 (mean 6.0) years ≥10 (mean 13.1) years
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Webtable 4: Change in BMI from baseline to a repeat measurement, by baseline BMI 
Baseline BMI No. Mean BMI No. Change (SE) No. Change (SE) No. Change (SE)
15-20 64 703 18.91 3 929 0.43 (0.02) 8 844 0.62 (0.02) 888 2.02 (0.08)
20-25 427 682 22.76 26 800 0.26 (0.01) 48 478 0.44 (0.01) 4 942 1.59 (0.04)
25-30 287 628 26.94 22 900 0.04 (0.01) 29 894 0.21 (0.01) 3 473 0.90 (0.05)
30-50 72 811 33.08 7 930 -0.13 (0.03) 8 114 0.12 (0.03) 1 275 -0.38 (0.11)
30-35 58 337 31.79 5 986 -0.07 (0.03) 6 275 0.24 (0.03) 974 0.02 (0.11)
35-40 11 195 36.90 1 460 -0.29 (0.07) 1 388 -0.18 (0.10) 237 -0.89 (0.29)
40-50 3 279 43.04 484 -0.45 (0.15) 451 -0.69 (0.21) 64 -4.51 (0.70)
14.17 0.56 (0.03) 0.50 (0.04) 2.40 (0.14)
Reduction in range, as % of baseline range: 4 4 17
* Excluding 41 752 with less than 5 years of follow-up
† 30-50 kg/m2 at baseline vs 15-20 kg/m2 at baseline
No. of people* at baseline, and their       
mean BMI (kg/m2):
No. of people resurveyed, and their                                            
change in BMI from baseline to first repeat measurement at:
Difference, 30-50 vs. 15-20†:
0-4 (mean 2.6) years* 5-9 (mean 6.0) years ≥10 (mean 13.1) years
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Webtable 5: Other cross-sectional associations* with BMI: height, cigarettes smoked per day, and grams of alcohol
consumed per day
Mean SE Mean SE Mean SE
Male 15-17.5 2 454 16.8 1.73 0.0013  811 18.1 0.33  265 18.8 1.04
17.5-20 26 432 19.1 1.73 0.0004 8 369 18.3 0.11 2 651 16.8 0.33
20-22.5 96 693 21.4 1.73 0.0002 24 930 18.6 0.06 14 118 16.6 0.14
22.5-25 168 043 23.8 1.73 0.0002 36 624 18.7 0.05 31 528 16.6 0.10
25-27.5 145 249 26.1 1.73 0.0002 30 013 19.0 0.05 29 724 16.8 0.10
27.5-30 65 434 28.6 1.73 0.0003 13 930 19.6 0.08 12 846 17.7 0.15
30-32.5 24 891 31.0 1.72 0.0004 5 105 19.7 0.13 5 062 18.2 0.24
32.5-35 8 008 33.5 1.72 0.0007 1 593 20.5 0.24 1 800 18.7 0.40
35-50 4 248 37.5 1.71 0.0010  843 20.6 0.33 1 102 17.0 0.51
All 541 452 24.9 1.73 122 218 18.9 99 096 17.0
Female 15-17.5 3 460 16.8 1.62 0.0010  514 15.8 0.38  358 8.5 0.51
17.5-20 35 673 19.1 1.62 0.0003 4 212 15.2 0.13 4 198 7.7 0.15
20-22.5 90 994 21.3 1.62 0.0002 11 605 15.1 0.08 14 208 7.7 0.08
22.5-25 90 033 23.7 1.62 0.0002 12 009 15.1 0.08 15 495 7.4 0.08
25-27.5 59 458 26.2 1.61 0.0002 7 687 15.1 0.10 10 558 7.0 0.09
27.5-30 32 545 28.7 1.61 0.0003 3 936 15.1 0.14 5 399 6.5 0.13
30-32.5 19 473 31.1 1.60 0.0004 2 229 16.0 0.18 3 151 6.3 0.17
32.5-35 9 979 33.6 1.60 0.0006 1 140 15.8 0.18 1 630 5.5 0.24
35-50 11 509 38.6 1.60 0.0006 1 174 16.0 0.25 1 807 5.3 0.23
All 353 124 24.6 1.61 44 506 15.2 56 804 7.2
NB This table includes all participants irrespective of follow-up duration.
* At ages 35-89 years. Associations adjusted for age (7 groups) and study; association for alcohol also adjusted for smoking status (3 groups).
† Restricted to current smokers (cf. fig 1) in the 33 cohorts with information on cigarettes per day. Excludes smokers with values recorded as 0 cigarettes/day;
>60 cigarettes/day taken as 60 cigarettes/day.
‡ Restricted to current regular drinkers (cf. fig 1) in the 21 cohorts with information on both current drinking status and alcohol grams/day. Excludes drinkers
with values recorded as 0 g/day; >100 g/day taken as 100 g/day.
§ In the full BMI range (15-50 kg/m2), 5 kg/m2 lower BMI was associated with 0.5 fewer cigarettes per day per smoker (male 0.65 SE 0.04, female 0.18 
SE 0.05), but — in a separate analysis of 2772 British smokers (not in the PSC) — with 11.8% (SE 1.4) more cotinine per ml of blood among those smoking 
similar numbers of cigarettes (Parish S et al. BMJ 1995; 311: 471-77 & personal communication). See also Istvan et al. Am J Epidemiol 2008; 139: 628-36 and







Height Alcohol g/dayNo. of 
drinkers
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Webtable 6: All-cause, vascular, diabetic, hepatic and renal mortality vs. baseline BMI in the ranges 15-25,
25-50 and (for selected endpoints) 15-50 kg/m2: hazard ratio (HR) per 5 kg/m2 higher BMI; HR < 1 if BMI 
inversely associated with risk
15-50 kg/m2
Deaths HR (95% CI) Deaths HR (95% CI) HR (95% CI)
ALL CAUSES 35 256 0.79 (0.77-0.82) 37 493 1.29 (1.27-1.32)
Male 26 720 0.79 (0.76-0.82) 27 983 1.32 (1.29-1.36)
Female 8 536 0.80 (0.75-0.85) 9 510 1.26 (1.23-1.30)
Never smoker 7 054 0.87 (0.81-0.94) 9 849 1.32 (1.28-1.36)
Current cigarette smoker 19 872 0.76 (0.73-0.80) 15 777 1.25 (1.21-1.29)
Other/unknown smoking at entry 8 330 0.81 (0.75-0.87) 11 867 1.32 (1.28-1.37)
Follow-up 0-4 years 8 158 0.62 (0.58-0.66) 7 838 1.18 (1.14-1.23)
Follow-up 5-9 years 11 319 0.70 (0.66-0.75) 11 738 1.25 (1.21-1.30)
Follow-up 10-14 years 10 763 0.81 (0.76-0.87) 11 419 1.34 (1.29-1.39)
Follow-up ≥ 15 years 13 174 0.85 (0.81-0.91) 14 336 1.30 (1.25-1.34)
Cohorts of US health professionals* 1 257 1.02 (0.78-1.33) 1 243 1.34 (1.19-1.52)
ALL VASCULAR DISEASE 13 073 1.05 (0.99-1.11) 17 343 1.41 (1.37-1.45)
Male 10 204 1.09 (1.02-1.17) 13 142 1.44 (1.39-1.50)
Female 2 869 0.90 (0.81-1.00) 4 201 1.36 (1.31-1.42)
Never smoker 2 687 1.04 (0.91-1.18) 4 668 1.43 (1.36-1.49)
Current cigarette smoker 7 232 1.03 (0.95-1.11) 7 210 1.34 (1.28-1.41)
Other/unknown smoking at entry 3 154 1.11 (0.98-1.26) 5 465 1.46 (1.39-1.54)
Follow-up 0-4 years 2 689 0.94 (0.83-1.06) 3 305 1.24 (1.16-1.32)
Follow-up 5-9 years 3 988 0.93 (0.84-1.04) 5 181 1.38 (1.31-1.46)
Follow-up 10-14 years 3 893 1.12 (1.00-1.26) 5 321 1.43 (1.36-1.51)
Follow-up ≥ 15 years 5 192 1.11 (1.01-1.22) 6 841 1.41 (1.35-1.47)
Ischaemic heart disease 7 461 1.22 (1.13-1.32)* 10 783 1.39 (1.34-1.44) 1.35 (1.32-1.38)†
Male 6 070 1.27 (1.16-1.39) 8 556 1.42 (1.35-1.48)
Female 1 391 1.01 (0.86-1.18) 2 227 1.35 (1.28-1.43)
Never smoker 1 323 1.20 (0.99-1.45) 2 651 1.41 (1.33-1.50)
Current cigarette smoker 4 327 1.20 (1.09-1.33) 4 690 1.33 (1.25-1.41)
Other/unknown smoking at entry 1 811 1.26 (1.07-1.50) 3 442 1.45 (1.36-1.54)
Follow-up 0-4 years 1 480 1.16 (0.98-1.38) 2 069 1.26 (1.16-1.36)
Follow-up 5-9 years 2 281 1.03 (0.89-1.20) 3 291 1.33 (1.24-1.43)
Follow-up 10-14 years 2 323 1.42 (1.21-1.66) 3 407 1.43 (1.33-1.53)
Follow-up ≥ 15 years 2 857 1.29 (1.13-1.47) 4 085 1.42 (1.34-1.51)
Stroke 2 964 0.92 (0.82-1.03) 3 164 1.39 (1.31-1.48)
   Ischaemic stroke  630 0.87 (0.68-1.10)  765 1.38 (1.23-1.56)
   Haemorrhagic stroke  536 0.76 (0.58-1.00)  571 1.53 (1.32-1.78)
   Subarachnoid haemorrhage  298 0.92 (0.64-1.33)  242 1.19 (0.94-1.52)
   Unclassified stroke 1 500 1.02 (0.87-1.20) 1 586 1.40 (1.28-1.53)
Other vascular disease‡ 2 648 0.84 (0.75-0.95) 3 396 1.47 (1.39-1.56)
Aortic aneurysm  279 1.09 (0.74-1.60)  386 1.19 (0.95-1.48) 1.37 (1.21-1.55)
Pulmonary embolism  113 0.88 (0.50-1.54)  145 1.24 (0.90-1.70) 1.14 (0.94-1.38)
Heart failure  328 0.93 (0.66-1.29)  289 1.86 (1.55-2.23)
Hypertensive disease  227 1.17 (0.77-1.76)  327 2.03 (1.75-2.36) 1.71 (1.53-1.91)
Atherosclerosis & other arterial dis.  239 0.69 (0.47-1.02)  216 1.07 (0.82-1.41) 0.92 (0.80-1.07)
Inflammatory heart disease  139 0.90 (0.51-1.59)  150 1.36 (1.01-1.84) 1.15 (0.95-1.39)
Rheumatic heart disease  93 0.64 (0.34-1.21)  96 0.90 (0.57-1.44) 0.93 (0.73-1.18)
Sudden death  199 0.95 (0.57-1.57)  281 1.44 (1.13-1.84) 1.35 (1.16-1.57)
Other heart disease (not IHD)  664 0.72 (0.57-0.91)  807 1.51 (1.34-1.70)
Other circulatory disease  57 0.65 (0.30-1.42)  102 1.47 (1.05-2.05) 1.46 (1.17-1.81)
DIABETES  171 0.96 (0.59-1.55)  393 2.16 (1.89-2.46)
KIDNEY DISEASE (non-neoplastic)  197 1.14 (0.74-1.77)  217 1.59 (1.27-1.99) 1.22 (1.06-1.41)
LIVER DISEASE (non-neoplastic)  489 0.69 (0.52-0.91)  603 1.82 (1.59-2.09)
Cirrhosis  409 0.73 (0.54-1.00)  505 1.79 (1.54-2.08)
Analyses exclude the first 5 years of follow-up (unless otherwise indicated: italic), and are adjusted for study, sex, age at risk
and baseline smoking status. Mean ages for IHD death and stroke death in various subgroups are given in figure 4, but
the dependence of the HR on mean age at death is not corrected for either in that figure or in this webtable. HRs for the 
full range (15-50 kg/m2) are not necessarily an average of the HRs for the two component ranges (cf. Simpson's paradox). 
For analyses restricted to those who had never smoked, see webtable 9.
* Studies of US physicians, nurses or other health professionals (webtable 1), in which there may have been relatively little 
confounding by socioeconomic status.
† IHD HR (95% CI): 1.27 (1.17-1.38) for 17.5-25 kg/m2, and 1.36 (1.33-1.39) for 17.5-50 kg/m 2  [1.31 (1.28-1.34) before 
adjustment for smoking status]
‡ Unspecified other vascular disease: 310 deaths at 15-25 kg/m2 (HR 0.83, 95% CI 0.58-1.18), 597 deaths at 25-50 kg/m 2
(HR 1.36,  95% CI 1.20-1.55)
15-25 kg/m2 25-50 kg/m2
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Webtable 7: Neoplastic mortality vs. baseline BMI in the ranges 15-25, 25-50 and (for selected categories) 
15-50 kg/m2: hazard ratio (HR) per 5 kg/m2 higher BMI; HR < 1 if BMI inversely associated with risk
15-50kg/m2
Deaths HR (95% CI) Deaths HR (95% CI) HR (95% CI)
ALL NEOPLASTIC DISEASE 11 772 0.82 (0.77-0.87) 10 820 1.10 (1.06-1.15)
Male 8 824 0.78 (0.73-0.84) 8 058 1.10 (1.04-1.16)
Female 2 948 0.98 (0.87-1.10) 2 762 1.11 (1.05-1.18)
Never smoker 2 190 0.96 (0.83-1.10) 2 704 1.13 (1.05-1.21)
Current cigarette smoker 6 870 0.77 (0.72-0.83) 4 637 1.06 (0.99-1.13)
Other/unknown smoking at entry 2 712 0.88 (0.77-1.00) 3 479 1.13 (1.05-1.21)
Follow-up 0-4 years 3 164 0.64 (0.57-0.71) 2 699 1.07 (1.00-1.15)
Follow-up 5-9 years 4 078 0.77 (0.69-0.85) 3 902 1.05 (0.98-1.12)
Follow-up 10-14 years 3 713 0.79 (0.70-0.88) 3 266 1.14 (1.06-1.24)
Follow-up ≥ 15 years 3 981 0.91 (0.82-1.01) 3 652 1.13 (1.05-1.21)
Lung cancer 2 959 0.71 (0.63-0.79) 2 040 0.98 (0.88-1.09) 0.80 (0.76-0.84)
Upper aerodigestive cancer  685 0.49 (0.39-0.61)  471 0.98 (0.79-1.20) 0.72 (0.65-0.81)
Oesophageal cancer  339 0.52 (0.38-0.72)  259 0.93 (0.69-1.24) 0.76 (0.65-0.88)
Lung and upper aerodig. cancer* 3 644 0.66 (0.59-0.73) 2 511 0.98 (0.89-1.07)
Follow-up 0-4 years  929 0.45 (0.37-0.54)  643 0.91 (0.77-1.08)
Follow-up 5-9 years 1 299 0.58 (0.48-0.69)  988 1.01 (0.87-1.17)
Follow-up 10-14 years 1 164 0.65 (0.53-0.79)  801 0.96 (0.80-1.16)
Follow-up ≥ 15 years 1 181 0.75 (0.62-0.91)  722 0.95 (0.78-1.15)
Cancer, not lung or upper aerodig.* 6 134 0.94 (0.87-1.02) 6 190 1.12 (1.06-1.18)
Follow-up 0-4 years 1 879 0.78 (0.68-0.90) 1 741 1.14 (1.06-1.24)
Follow-up 5-9 years 2 311 0.88 (0.76-1.02) 2 390 1.04 (0.95-1.14)
Follow-up 10-14 years 2 042 0.91 (0.78-1.07) 1 974 1.17 (1.06-1.30)
Follow-up ≥ 15 years 1 781 1.04 (0.88-1.23) 1 826 1.17 (1.06-1.29)
Liver cancer  201 1.37 (0.87-2.15)  221 1.61 (1.26-2.05) 1.47 (1.26-1.71)
Kidney cancer  193 1.02 (0.64-1.64)  254 1.30 (1.02-1.67) 1.23 (1.06-1.43)
Female breast cancer, age < 60†  291 1.51 (1.01-2.25)  171 1.10 (0.88-1.39) 1.15 (1.02-1.31)
Female breast cancer, age ≥ 60†  192 1.06 (0.66-1.70)  228 1.11 (0.91-1.36) 1.15 (1.02-1.31)
Ovarian cancer  182 0.74 (0.47-1.18)  158 0.98 (0.75-1.28) 1.00 (0.85-1.16)
Endometrial cancer  35 0.97 (0.32-2.94)  67 1.18 (0.80-1.74) 1.38 (1.08-1.77)
Prostate cancer  578 1.00 (0.75-1.32)  665 1.09 (0.91-1.31) 1.13 (1.02-1.24)
Pancreatic cancer  470 0.87 (0.65-1.17)  520 1.04 (0.86-1.25) 1.07 (0.97-1.19)
Gallbladder cancer  102 0.46 (0.26-0.80)  120 1.29 (0.90-1.85) 1.12 (0.90-1.38)
Stomach cancer  934 0.86 (0.70-1.05)  651 1.11 (0.94-1.32) 0.98 (0.90-1.07)
Colorectal cancer‡ 1 054 1.01 (0.83-1.24) 1 200 1.20 (1.07-1.35) 1.20 (1.12-1.28)
Male  782 0.99 (0.77-1.26)  931 1.32 (1.14-1.52) 1.29 (1.19-1.40)
Female  272 1.08 (0.74-1.57)  269 1.04 (0.86-1.26) 1.05 (0.94-1.18)
Haematological cancer  765 1.11 (0.87-1.42)  828 1.10 (0.95-1.27) 1.11 (1.02-1.20)
Leukaemia  290 1.02 (0.69-1.50)  315 0.88 (0.68-1.14) 1.01 (0.89-1.16)
Non-Hodgkin's lymphoma  193 1.19 (0.70-2.02)  196 1.09 (0.81-1.47) 1.13 (0.96-1.34)
Multiple myeloma  138 1.38 (0.77-2.48)  190 1.34 (1.01-1.77) 1.27 (1.07-1.50)
Other specified cancer 1 137 0.87 (0.71-1.06) 1 107 1.00 (0.87-1.14) 0.98 (0.92-1.06)
Unspecified cancer 1 994 0.83 (0.72-0.96) 2 119 1.17 (1.08-1.27)
Analyses exclude the first 5 years of follow-up (unless otherwise indicated: italic), and are adjusted for study, sex, age at risk
and baseline smoking status. HRs for the full range (15-50 kg/m2) are not necessarily an average of the HRs for the two
component ranges (cf. Simpson's paradox). For analyses restricted to those who had never smoked, see webtable 9.
* These are the cancer endpoints in figure 5; they do not include unspecified cancer.
† By chance, the two age-specific breast cancer results for the range 15-50 kg/m2 were the same to two decimal places. 
‡ Difference between male and female HRs: P for interaction = 0.08 in the range 25-50 kg/m2, 0.002 in the full range
15-50 kg/m2.
15-25 kg/m2 25-50 kg/m2
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Webtable 8: Respiratory mortality, and remaining causes, vs. baseline BMI in the ranges 15-25 and 25-50
kg/m2: hazard ratio (HR) per 5 kg/m2 higher BMI; HR < 1 if BMI inversely associated with risk
Deaths HR (95% CI) Deaths HR (95% CI)
ALL RESPIRATORY DISEASE 2 426 0.31 (0.28-0.35) 1 344 1.20 (1.07-1.34)
Male 1 993 0.31 (0.27-0.35) 1 086 1.17 (1.01-1.34)
Female  433 0.32 (0.25-0.41)  258 1.24 (1.04-1.48)
Never smoker  370 0.48 (0.36-0.65)  257 1.16 (0.93-1.45)
Current cigarette smoker 1 497 0.29 (0.25-0.34)  645 1.26 (1.07-1.48)
Other/unknown smoking at entry  559 0.26 (0.20-0.34)  442 1.15 (0.93-1.40)
Follow-up 0-4 years  447 0.14 (0.11-0.18)  199 1.35 (1.07-1.71)
Follow-up 5-9 years  713 0.25 (0.20-0.31)  375 1.08 (0.85-1.37)
Follow-up 10-14 years  757 0.30 (0.24-0.37)  439 1.26 (1.02-1.55)
Follow-up ≥ 15 years  956 0.37 (0.30-0.44)  530 1.15 (0.94-1.39)
Chronic obstructive pulmonary disease 1 340 0.26 (0.22-0.30)  614 1.18 (1.00-1.40)
Follow-up 0-4 years  255 0.11 (0.08-0.16)  87 1.12 (0.74-1.69)
Follow-up 5-9 years  360 0.21 (0.15-0.28)  186 0.99 (0.68-1.44)
Follow-up 10-14 years  409 0.22 (0.16-0.29)  187 1.25 (0.90-1.74)
Follow-up ≥ 15 years  571 0.31 (0.24-0.40)  241 1.24 (0.93-1.65)
Pneumonia  695 0.46 (0.37-0.57)  482 1.15 (0.96-1.38)
Respiratory tuberculosis  120 0.08 (0.04-0.13)  16 -
   Excluding 10 years of follow-up  72 0.09 (0.04-0.19)  7 -
Other respiratory disease  271 0.48 (0.34-0.69)  232 1.34 (1.04-1.72)
OTHER SPECIFIED DISEASE* 2 049 0.62 (0.54-0.71) 1 823 1.20 (1.10-1.31)
Male 1 536 0.60 (0.51-0.70) 1 363 1.30 (1.16-1.47)
Female  513 0.67 (0.52-0.87)  460 1.09 (0.94-1.25)
Never smoker  532 0.62 (0.47-0.81)  523 1.31 (1.13-1.52)
Current cigarette smoker  953 0.63 (0.52-0.77)  684 1.22 (1.04-1.42)
Other/unknown smoking at entry  564 0.59 (0.45-0.78)  616 1.07 (0.91-1.27)
EXTERNAL CAUSE 2 112 0.82 (0.71-0.95) 1 720 1.19 (1.08-1.32)
Male 1 641 0.88 (0.74-1.04) 1 424 1.23 (1.09-1.38)
Female  471 0.66 (0.50-0.87)  296 1.12 (0.94-1.34)
Never smoker  506 0.84 (0.62-1.13)  510 1.19 (1.01-1.41)
Current cigarette smoker 1 128 0.78 (0.65-0.95)  695 1.21 (1.03-1.43)
Other/unknown smoking at entry  478 0.86 (0.63-1.18)  515 1.17 (0.97-1.41)
UNKNOWN CAUSE 2 967 0.66 (0.59-0.73) 3 230 1.24 (1.17-1.32)
Male 1 839 0.63 (0.55-0.73) 1 988 1.27 (1.16-1.40)
Female 1 128 0.67 (0.56-0.79) 1 242 1.22 (1.12-1.32)
Never smoker  599 0.73 (0.57-0.95)  842 1.26 (1.13-1.40)
Current cigarette smoker 1 709 0.64 (0.56-0.74) 1 410 1.20 (1.08-1.32)
Other/unknown smoking at entry  659 0.62 (0.48-0.80)  978 1.28 (1.15-1.43)
Analyses exclude the first 5 years of follow-up (unless otherwise indicated: italic), and are adjusted for study, sex, age at risk
and baseline smoking status. For analyses restricted to those who had never smoked, see webtable 9. 
* Specified diseases other than vascular, neoplastic, respiratory, hepatic or renal diseases, and other than diabetes; see 
webtable 2.
15-25 kg/m2 25-50 kg/m2
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Webtable 9: Selected mortality in the ranges 15-25 and 25-50 kg/m2 among lifelong non-smokers:
hazard ratio (HR) per 5 kg/m2 higher BMI; HR < 1 if BMI inversely associated with risk
Deaths HR (95% CI) Deaths HR (95% CI)
ALL CAUSES 7 054 0.87 (0.81-0.94) 9 849 1.32 (1.28-1.36)
Male* 3 694 0.87 (0.78-0.97) 4 811 1.44 (1.36-1.53)
Female* 3 360 0.87 (0.78-0.97) 5 038 1.27 (1.22-1.32)
Follow-up ≥ 10 years 4 719 0.89 (0.81-0.98) 6 900 1.34 (1.28-1.39)
Cohorts of US health professionals†  450 1.30 (0.82-2.05)  418 1.21 (0.96-1.54)
ALL VASCULAR DISEASE 2 687 1.04 (0.91-1.18) 4 668 1.43 (1.36-1.49)
Ischaemic heart disease‡ 1 323 1.20 (0.99-1.45) 2 651 1.41 (1.33-1.50)
Stroke  751 0.98 (0.78-1.23) 1 062 1.38 (1.25-1.52)
   Ischaemic stroke  203 1.07 (0.68-1.67)  361 1.36 (1.16-1.60)
   Haemorrhagic stroke  134 0.91 (0.51-1.62)  197 1.37 (1.09-1.73)
   Subarachnoid haemorrhage  66 1.24 (0.56-2.76)  74 1.19 (0.82-1.74)
   Unclassified stroke  348 0.95 (0.68-1.32)  430 1.48 (1.26-1.73)
Other vascular disease  613 0.85 (0.66-1.09)  955 1.52 (1.38-1.67)
DIABETES, LIVER OR KIDNEY DISEASE  170 1.12 (0.69-1.81)  345 1.82 (1.56-2.11)
Diabetes‡  39 2.46 (0.75-8.01)  135 1.88 (1.50-2.36)
Kidney disease (non-neoplastic)  62 0.92 (0.43-1.96)  76 2.01 (1.51-2.69)
Liver disease (non-neoplastic)  69 0.93 (0.44-1.95)  134 1.60 (1.20-2.12)
Cirrhosis  52 0.96 (0.40-2.31)  107 1.63 (1.18-2.25)
ALL NEOPLASTIC DISEASE 2 190 0.96 (0.83-1.10) 2 704 1.13 (1.05-1.21)
Lung cancer‡  122 0.90 (0.48-1.68)  117 0.82 (0.55-1.24)
Upper aerodigestive cancer  54 0.35 (0.16-0.74)  60 1.00 (0.56-1.78)
Other specified cancer 1 594 0.99 (0.83-1.17) 1 833 1.10 (1.00-1.20)
Unspecified cancer  420 1.03 (0.75-1.42)  694 1.24 (1.10-1.40)
ALL RESPIRATORY DISEASE  370 0.48 (0.36-0.65)  257 1.16 (0.93-1.45)
Chronic obstructive pulmonary disease  135 0.38 (0.23-0.62)  77 1.09 (0.68-1.74)
Follow-up ≥ 10 years  92 0.40 (0.21-0.74)  61 1.15 (0.70-1.90)
Pneumonia  149 0.61 (0.38-0.98)  122 1.05 (0.75-1.46)
Respiratory tuberculosis  29 0.10 (0.04-0.29)  2 -
Other respiratory disease  57 1.13 (0.48-2.70)  56 1.49 (1.00-2.22)
OTHER SPECIFIED DISEASE  532 0.62 (0.47-0.81)  523 1.31 (1.13-1.52)
EXTERNAL CAUSE  506 0.84 (0.62-1.13)  510 1.19 (1.01-1.41)
UNKNOWN CAUSE  599 0.73 (0.57-0.95)  842 1.26 (1.13-1.40)
Analyses exclude the first 5 years (or 10 years: italic) of follow-up, and are adjusted for study, sex and age at risk.
* By chance, the all-cause 15-25 kg/m2 results for the two sexes were the same to two decimal places.
† Studies of US physicians, nurses or other health professionals (webtable 1), in which there may have been 
relatively little confounding by socioeconomic status.
‡ HR (95% CI) for full BMI range (15-50 kg/m2): IHD 1.36 (1.30-1.42); diabetes 2.03 (1.72-2.41); lung cancer
 0.99 (0.81-1.22).
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Webtable 10: Assumed causal relative risks used to estimate* figure 7 survival curves
Cause of death 22.5-25 25-30 30-35 35-40 40-50
Ischaemic heart disease 35-59 0.73 1 1.48 2.25 3.70
60-69 0.83 1 1.47 1.94 2.92
70-79 0.84 1 1.40 1.70 2.36
Stroke 35-59 0.95 1 1.72 3.10 6.19
60-69 0.82 1 1.52 2.20 3.57
70-79 0.95 1 1.35 1.75 2.47
Other vascular disease 35-59 0.89 1 1.83 2.81 5.30
60-69 0.82 1 1.57 2.52 4.45
70-79 0.82 1 1.28 1.88 2.78
Diabetes 35-79 0.58 1 2.57 4.90 13.05
Kidney disease (non-neoplastic) 35-79 1.13 1 1.88 2.71 5.02
Liver disease (non-neoplastic) 35-79 0.71 1 1.75 3.23 6.64
Liver and gallbladder cancer 35-79 0.74 1 2.05 2.43 4.19
Kidney cancer 35-79 0.80 1 1.34 1.64 2.21
Colorectal cancer, male‡ 35-79 0.83 1 1.23 1.53 2.0**
Colorectal cancer, female‡ 35-79 0.91 1 1.21 1.24 1.33
Endometrial cancer‡§ 35-79 0.67 1 1.69 1.85 4.17
Female breast cancer, age < 60 35-59 1 1 1 1 1
Female breast cancer, age ≥ 60 ‡║ 60-79 0.75 1 1.22 1.27 1.58
Ovarian cancer‡ 35-79 0.87 1 1.01 1.31 1.5**
Prostate cancer 35-79 0.89 1 1.12 1.23 1.39
Pancreatic cancer 35-79 0.85 1 1.12 1.17 1.28
Lung & upper aerodig. cancer†† 35-79 (1.11) 1 (0.96) (0.92) (0.88)
Other specified cancer†† 35-79 (0.99) 1 (1.03) (1.08) (1.13)
Unspecified cancer - - - - - -
Respiratory disease†† 35-79 (1.09) 1 (1.10) (1.51) (1.95)
Other specified disease†† 35-79 (1.02) 1 (1.24) (1.72) (2.36)
External cause†† 35-79 (1.01) 1 (1.18) (1.44) (1.28)
Unknown cause - - - - - -
* The causal relative risks were applied to EU 2000 cause-specific death rates at ages 35-39 to 75-79 (with summation yielding the all-cause rates). 
For older ages, the BMI-specific relative risks for all-cause mortality at ages 75-79 (relative to BMI 25-30 kg/m2) were applied to estimates 
of the all-cause death rates for single years of age in England and Wales in 2000. (As a sensitivity analysis, the square roots of these  relative
risks yielded similar results.)
† Relative risks (RR) are from the PSC unless indicated otherwise. These RRs were adjusted for study, age at risk, sex and baseline smoking, and
the first 5 years of follow-up were excluded. The RRs for vascular disease were assumed to depend on age but not, given age, on sex. (The lower 
RRs for women than for men in figure 4 chiefly reflect the difference between the sexes in mean age at death.) RRs in italics were, to improve 
statistical stability, calculated from regressions on BMI as a continuous variable in the range 25-50 kg/m2 (or, for prostate and pancreatic cancers, 
15-50 kg/m2).
‡ These RRs are, for greater statistical stability, from the Cancer Prevention Study-II (CPS-II),4 and were adjusted for age, smoking, physical 
activity and education (among other variables). Mean age at baseline in CPS-II was 57 years, and deaths were recorded during follow-up for
16 years. Analyses did not exclude early follow-up, but did exclude anyone with a history of cancer or recent notable weight loss. CPS-II RRs
for the 18.5-24.9 kg/m2 category have been inserted above into the 22.5-25 kg/m2 column. 
§ In CPS-II but not PSC, endometrial cancer included ICD-9 179 (uterus, part unspecified).
║ Defined in CPS-II as postmenopausal breast cancer.
** RR unavailable in CPS-II, but estimated here from the trend in RRs across lower BMI groups
†† For these causes of death the RRs describing the associations of BMI with risk in the PSC are given in parentheses, as it was assumed in
estimating the effects of BMI on mortality for figure 7 that these associations could have been non-causal (ie, these RRs were taken as 1.0 in
calculating figure 7). Sensitivity analyses that instead used the RRs in parentheses showed that this assumption did not materially alter the
median survival in any BMI category.
Relative risk† for baseline BMI (kg/m2) rangeAge at risk 
(years)
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Webtable 11: Cumulative mortality at ages 35-79 implied by webtable 10: male
Cause of death 22.5-25 25-30 30-35 35-40 40-50
Ischaemic heart disease 35-59 1.1 1.6 2.3 3.5 5.8
60-69 2.7 3.3 4.8 6.3 9.5
70-79 7.4 8.8 12.3 14.9 20.7
Stroke 35-59 0.4 0.4 0.7 1.3 2.6
60-69 0.9 1.0 1.6 2.3 3.7
70-79 4.0 4.3 5.8 7.5 10.5
Other vascular disease 35-59 0.7 0.8 1.5 2.3 4.4
60-69 1.4 1.7 2.7 4.4 7.8
70-79 4.6 5.7 7.2 10.7 15.7
ALL VASCULAR 35-79 23.3 27.6 39.0 53.2 80.8
Diabetes 35-79 0.9 1.5 3.8 7.3 19.5
Kidney disease (non-neoplastic) 35-79 0.7 0.6 1.2 1.7 3.2
Liver disease (non-neoplastic) 35-79 1.5 2.1 3.7 6.8 14.0
ALL HEPATO-RENAL-DIABETIC 35-79 3.1 4.3 8.7 15.9 36.8
Liver and gallbladder cancer 35-79 0.9 1.2 2.5 2.9 5.1
Kidney cancer 35-79 0.6 0.8 1.0 1.2 1.7
Colorectal cancer, male 35-79 2.5 3.1 3.7 4.7 6.1
Prostate cancer 35-79 2.2 2.4 2.7 3.0 3.4
Pancreatic cancer 35-79 1.1 1.3 1.5 1.5 1.7
Lung cancer 35-79 10.5 10.5 10.5 10.5 10.5
Other specified cancer 35-79 7.5 7.5 7.5 7.5 7.5
Unspecified cancer† 35-79 0.0 0.0 0.0 0.0 0.0
ALL NEOPLASTIC 35-79 25.3 26.8 29.4 31.4 35.9
Respiratory disease 35-79 6.7 6.7 6.7 6.7 6.7
Other specified disease 35-79 6.7 6.7 6.7 6.7 6.7
External cause 35-79 3.4 3.4 3.4 3.4 3.4
Unknown cause† 35-79 0.0 0.0 0.0 0.0 0.0
ALL CAUSES (and corresponding‡ 35-79 68.6 75.4 93.9 117.3 170.3
risk of 35 year old dying before 80) (50%) (53%) (61%) (69%) (82%)
* For the BMI 25-30 kg/m2 category, the cumulative mortality in a given range of ages at risk is assumed to be the total 
duration in years (eg, 25 for the range 35-59) times the average of the annual death rates in each of the 5-year age
ranges within it (eg, 35-39, 40-44 etc). The death rates are those for the European Union in 2000 (ie, the aggregate of 
15 western European countries). For the other BMI categories, the cumulative mortality is assumed to be that at BMI 
25-30 kg/m2 multiplied by the corresponding relative risk in webtable 10 (unless the relative risk is in parentheses, in 
which case the multiplier is 1). Cumulative mortalities in different age ranges, or from different causes of death, are 
exactly additive.
† Unspecified cancer deaths were redistributed over the other neoplastic categories by dividing each category's rate
by 1 minus the proportion of neoplastic deaths that were unspecified (ie, by 0.94). Deaths from unknown cause were
then redistributed over all other mortality categories (including the neoplastic categories) by dividing each category's 
rate by 1 minus the proportion of all deaths that had an unknown cause (ie, by 0.98).
‡ If the cumulative mortality at ages 35-79 is c % then the probability that a 35-year-old will die before age 80 is 
1 - exp(-c /100). For example, if c = 75.4 then the survival probability is 1 - exp(-0.754) = 0.53.
            
Age at risk 
(years)
Cumulative mortality* (%) for                      
baseline BMI (kg/m2) range
Printed 20/01/2009 15:05 - K:\vep\PSC\PAPERS\BMI\All causes vs BMI\MASTER DRAFTS\PSC BMI tables and webtables (Times New Roman).xls
Webtable 12: Cumulative mortality at ages 35-79 implied by webtable 10: female
Cause of death 22.5-25 25-30 30-35 35-40 40-50
Ischaemic heart disease 35-59 0.2 0.3 0.5 0.7 1.1
60-69 0.8 1.0 1.5 2.0 2.9
70-79 3.5 4.1 5.8 7.0 9.8
Stroke 35-59 0.3 0.3 0.5 0.8 1.6
60-69 0.5 0.6 0.9 1.3 2.1
70-79 2.9 3.0 4.1 5.3 7.5
Other vascular disease 35-59 0.3 0.3 0.6 1.0 1.8
60-69 0.7 0.8 1.3 2.1 3.7
70-79 3.0 3.7 4.7 6.9 10.2
ALL VASCULAR 35-79 12.1 14.2 19.8 27.1 40.8
Diabetes 35-79 0.7 1.1 2.9 5.5 14.7
Kidney disease (non-neoplastic) 35-79 0.4 0.4 0.7 1.0 1.9
Liver disease (non-neoplastic) 35-79 0.7 0.9 1.6 3.0 6.2
ALL HEPATO-RENAL-DIABETIC 35-79 1.8 2.5 5.3 9.6 22.9
Liver and gallbladder cancer 35-79 0.4 0.6 1.1 1.3 2.3
Kidney cancer 35-79 0.3 0.3 0.4 0.5 0.7
Colorectal cancer, female 35-79 1.6 1.8 2.1 2.2 3.5
Endometrial cancer 35-79 0.1 0.2 0.4 0.4 0.4
Female breast cancer, age <60 35-59 0.9 0.9 0.9 0.9 0.9
Female breast cancer, age ≥ 60 60-79 1.5 2.0 2.4 2.5 4.0
Ovarian cancer 35-79 0.8 1.0 1.0 1.3 1.9
Pancreatic cancer 35-79 0.8 0.9 1.0 1.1 1.2
Lung cancer 35-79 2.4 2.4 2.4 2.4 2.4
Other specified cancer 35-79 4.3 4.3 4.3 4.3 4.3
Unspecified cancer† 35-79 0.0 0.0 0.0 0.0 0.0
ALL NEOPLASTIC 35-79 13.1 14.4 16.1 16.9 21.7
Respiratory disease 35-79 2.9 2.9 2.9 2.9 2.9
Other specified disease 35-79 4.5 4.5 4.5 4.5 4.5
External cause 35-79 1.4 1.4 1.4 1.4 1.4
Unknown cause† 35-79 0.0 0.0 0.0 0.0 0.0
ALL CAUSES (and corresponding‡ 35-79 35.8 39.7 49.9 62.4 94.2
risk of 35 year old dying before 80) (30%) (33%) (39%) (46%) (61%)
Footnotes as in webtable 11.
            
Age at risk 
(years)
Cumulative mortality* (%) for                      
baseline BMI (kg/m2) range
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